DEC 23, 2019 9:46 AM PST

Eye Solution Approved for Surgical Application

WRITTEN BY: Nouran Amin

As announced by the Dutch Ophthalmic Research Center in a press release, a new eye solution was recently approved by the US Food and Drug Administration for surgical application. The dye is called Brilliant Blue G ophthalmic solution and is used for staining the internal limiting membrane (ILM) of the eye.

“Brilliant Blue G, intended to stain and distinguish the ILM from the retina to facilitate removal, will be the first FDA-approved product for this indication,” the release said.

Although the Brilliant Blue G (BBG) ophthalmic solution has been in use for staining for internal limiting membrane (ILM) in Europe during the past decade, no commercial formulation was approved by the FDA. Instead, an off-label indocyanine green (ICG) was the common used dye utilized for staining the ILM in the United States.

Studies have addressed differences in visual outcomes that are more improved with the BBG as opposed with the ICG. Furthermore, clinical and library analyses confirmed that there retinal toxicity with ICG use including cell death. In addition, BBG utilizes polyethylene glycol and has a high attachment rate to ILM as opposed to another membrane known as epiretinal membrane (ERM) which allows BBG to function as a negative stain for ERM. The BBG staining and ophthalmic solution also increases ILM rigidity and can aid in ILM peeling with more efficacy and safety and potentially produce better patient outcomes.

Learn more about ILM peeling:

“DORC has always worked closely with surgeons around the world to develop practical advancements in treating eye disorders” Thierry Leclercq, CEO of DORC International, said in the release. “The Brilliant Blue G ophthalmic solution submission is just another example of DORC responding to market needs. We look forward to working with the FDA throughout the review process.”

Source: Healio.com

 

About the Author
  • Nouran earned her BS and MS in Biology at IUPUI and currently shares her love of science by teaching. She enjoys writing on various topics as well including science & medicine, global health, and conservation biology. She hopes through her writing she can make science more engaging and communicable to the general public.
You May Also Like
JUL 20, 2020
Neuroscience
Phantom-Limb Pain Reduced by Brain-Computer Interface
JUL 20, 2020
Phantom-Limb Pain Reduced by Brain-Computer Interface
Phantom-limb pain is a condition in which amputees feel like their amputated limb is still attached to their bodies. Whi ...
JUL 29, 2020
Cancer
Regulating Apoptosis in Prostate Cancer
JUL 29, 2020
Regulating Apoptosis in Prostate Cancer
Cancer treatments tend to work in one of a few ways. They can target the immune system, prevent cancer proliferation and ...
AUG 11, 2020
Drug Discovery & Development
Scientists Discover Key Gene Behind Antibiotic Resistance
AUG 11, 2020
Scientists Discover Key Gene Behind Antibiotic Resistance
Scientists from Oxford University have shown that a single gene can make some strains of Staphylococcus aureus (the bact ...
AUG 17, 2020
Drug Discovery & Development
Therapy Found in The Shell of Cashews
AUG 17, 2020
Therapy Found in The Shell of Cashews
A compound found in the shell of cashews can help in neurodegeneration. "We see this as an exciting finding, sugges ...
AUG 22, 2020
Drug Discovery & Development
New Class of Antibiotics Could Treat UTIs
AUG 22, 2020
New Class of Antibiotics Could Treat UTIs
At 11 million cases annually, urinary tract infections (UTIs) are the most common outpatient infections in the U.S., Sci ...
SEP 20, 2020
Drug Discovery & Development
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
SEP 20, 2020
New Drug Combo Prolongs Survival with Advanced Kidney Cancer
Biopharmaceutical company Bristol-Myers Squibb has found that a new drug combination can reduce death rates among those ...
Loading Comments...